Cargando…
(1β,2α,3α,7α,11α,13β)-1,3,7,11-Tetraacetoxy-2,13-bis(benzyloxy)-21-methyl-19,21-secohetisan-19-al hemihydrate
In the crystal structure of the title compound, C(43)H(46)NO(13)·0.5H(2)O, the molecule assumes a U-shaped conformation, the terminal benzene rings being approximately parallel and partially overlapped with each other. The molecule contains eight alicyclic and heterocyclic rings. The cyclohexane...
Autores principales: | Chen, Feng-Zheng, Xiang, Qing-Xiang, Zhang, Yuan-Qin, Xiong, Jun-Ru |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2969740/ https://www.ncbi.nlm.nih.gov/pubmed/21583273 http://dx.doi.org/10.1107/S1600536809018315 |
Ejemplares similares
-
(1α,2β,3α,7α,11α,13β)-1,3,11-Triacetoxy-2,13-bis(benzyloxy)-7-hydroxy-21-methyl-N,19-secohetisan-19-al
por: Li, Shu-Hua, et al.
Publicado: (2008) -
(20R,24R,25S)-3α,7α,12α,27-Tetraacetoxy-24,26-epoxy-5β-cholestane
por: Ketuly, Kamal Aziz, et al.
Publicado: (2009) -
1α,6β,7β,11α,15β-Pentahydroxy-7α,20-epoxy-ent-kaur-16-ene
por: Feng, Chuang, et al.
Publicado: (2010) -
1α,11α,15β-Triacetoxy-7β-hydroxy-7α,20-epoxy-ent-kaur-16-en-6-one
por: Yan, Fu-Lin, et al.
Publicado: (2009) -
A New 2α,5α,10β,14β-tetraacetoxy-4(20),11-taxadiene (SIA) Derivative Overcomes Paclitaxel Resistance by Inhibiting MAPK Signaling and Increasing Paclitaxel Accumulation in Breast Cancer Cells
por: Mei, Mei, et al.
Publicado: (2014)